You are here: Industry Insights > Gene Editing

News List

Gene Editing Destiny: The CRISPR Revolution and Beyond Shruti Talashi
August 01, 2024
Genome editing has the potential to eradicate hereditary illnesses, improve human potential, and transform biotechnology and agriculture with continued research and development.
Celonic Launches New GS-CHOvolution® Cell Line Expression System PharmaSources
April 10, 2024
GS-CHOvolution® is based on Revvity’s CHOSOURCE™ expression platform and TnT transposon technology.
Initial CRISPR Gene Editing Therapy has been Approved. What is the Domestic Progress? Yefenghong/PharmaSources
December 14, 2023
Vertex Pharmaceuticals and CRISPR Therapeutics announced that their jointly developed CRISPR gene editing therapy CASGEVY has been conditionally approved.
World First: CRISPR Gene Editing Approved in the UK David Orchard-Webb
December 01, 2023
The UK Medicines and Healthcare products Regulatory Agency granted conditional marketing approval for Vertex & CRISPR Therapeutics’ Casgevy to treat Sickle Cell Disease and transfusion-dependent beta thalassemia on November 16, 2023.
Strengthens Investment in Licensed mRNA Technology Platform with $20M Financing firstwordpharma
May 25, 2021
Brooklyn today announced it has completed a $20M financing to progress the development of the mRNA gene editing and cell therapies technology recently licensed from Factor Biosciences and Novellus Therapeutics.
Vertex and Obsidian partner to discover gene-editing medicines pharmaceutical-business-review
April 25, 2021
Vertex Pharmaceuticals and Obsidian Therapeutics have established a multi-year collaboration for the discovery of new treatments that regulate gene editing.
Pharma and Health from Ingredients to Pills: Cancer Therapeutics Today(2) Lin Zhang
July 28, 2020
In 2015, the advantages of the clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein (Cas)9-mediated genome modification......
Study shows CRISPR could help treat lung disease in utero pharmaceutical-technology
April 22, 2019
Study shows CRISPR could help treat lung disease in utero.
A better CRISPR? RNA 'hairpins' could improve gene editing fiercebiotech
April 17, 2019
One of the biggest worries holding back the burgeoning field of CRISPR gene editing is that the technology can make mistakes, causing off-target effects by cutting the wrong piece of DNA.
CRISPR gene editing stocks fall after Editas CEO resigns pharmaphorum
January 24, 2019
Shares in firms developing therapies based on CRISPR gene editing technology have fallen after the resignation of the CEO of one of the leading biotechs in the field, Editas.

Previous page 1 2 Next page